Marinova Pty Ltd

Marinova is an Australian biotechnology company founded in 2003 and headquartered in Australia, specializing in the research, development, and manufacture of high purity fucoidan compounds derived from select species of brown seaweed. Recognized globally as the leader in fucoidan science, the company supplies world-renowned research institutions, pharmaceutical developers, nutraceutical brands, cosmetic formulators, and animal health companies across international markets.

Fucoidan is a highly bioactive polysaccharide found naturally in brown seaweed, and Marinova has spent over two decades conducting rigorous scientific investigation into its structure, bioactivity, and applications. The company's proprietary aqueous extraction process produces high purity fucoidan compounds without the use of harsh chemicals, solvents, or elevated temperatures, resulting in a portfolio of highly characterized extracts with superior bioactivity profiles. This chemical-free extraction methodology is a key differentiator in the marketplace and underpins the global regulatory acceptance of its products.

Marinova is the world's only producer of high purity, certified organic fucoidan extracts with global regulatory acceptance. Its Maritech® product line represents a unique range of organic fucoidan extracts developed specifically for nutritional supplements, cosmetic formulations, and animal health applications. In addition to consumer-facing ingredient categories, the company produces highly characterized fucoidan fractions suited to medical device applications and pharmaceutical research, demonstrating the breadth and technical sophistication of its product portfolio.

The company maintains an active and extensive global research and development program, collaborating with leading universities and contract research organizations. Marinova's scientists are widely published authorities on the structure and bioactivity of algal polysaccharides, with deep expertise in the physical and chemical properties of fucoidan and how these can be modified to enhance efficacy for specific end-use applications. This scientific foundation, combined with proprietary manufacturing technologies, positions Marinova as a uniquely capable ingredient supplier for B2B customers requiring validated, high-integrity bioactive compounds.

From a certification and quality standpoint, Marinova holds organic certification for its Maritech® extracts and operates with a commitment to quality and characterization that supports both nutritional and pharmaceutical-grade applications. Its sustainable seaweed harvesting practices and advanced processing capabilities further reinforce its standing as a responsible and technically advanced ingredient manufacturer. With two decades of operational history and a reputation built on scientific rigor, Marinova serves as a trusted long-term partner for formulators and researchers seeking fucoidan-based ingredients with documented bioactivity and regulatory compliance.